The price of Mavyret, a treatment for chronic hepatitis C virus (HCV) infection, varies depending on factors such as insurance coverage, pharmacy, and geographic location. However, without insurance, the average retail price for a 12-week treatment course can be approximately $26,400. [1]
How much does Mavyret cost with insurance?
With insurance, the out-of-pocket cost for Mavyret can be significantly reduced. Many insurance plans offer co-pay assistance programs or cover a substantial portion of the drug's cost. Patients are advised to check with their insurance provider or Mavyret's manufacturer for specific coverage details and potential savings programs. [2]
Are there patient assistance programs for Mavyret?
Yes, AbbVie, the manufacturer of Mavyret, offers patient assistance programs to help eligible individuals access the medication. These programs, such as the AbbVie Patient Assistance Foundation, can provide financial support for those who meet certain income and insurance criteria. [2]
What is the generic availability of Mavyret?
As of late 2023, Mavyret is still under patent protection, meaning generic versions are not yet available. Patents for Mavyret are set to expire in the coming years, which could lead to the introduction of lower-cost generic alternatives. [3] DrugPatentWatch.com tracks patent expirations for various medications, including Mavyret. [3]
How does Mavyret's price compare to other hepatitis C treatments?
The cost of Mavyret is comparable to other direct-acting antiviral (DAA) treatments for hepatitis C. These newer DAA regimens, including Mavyret, generally come with high price tags, reflecting the significant research and development investment and their effectiveness in curing hepatitis C. [1] However, the development of generic versions of other hepatitis C drugs has led to substantial price reductions in the market. [4]